HR 3991 · 116th Congress 2019–2021, ended

Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act of 2019

Latest action · Nov 21, 2019 Ordered to be Reported (Amended).

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedJul 25, 2019
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act of 2019

This bill limits in certain instances the number of patents that the manufacturer of a biologic drug can assert in a lawsuit against a company seeking to sell a biosimilar version of that drug. (A biologic drug is produced through natural processes or isolated from natural sources. A biosimilar version is substantially similar to the original biologic, which is the reference product, and is often marketed as a less expensive alternative.)

The bill's provisions apply to an existing framework that gives the biosimilar manufacturer an abbreviated path to Food and Drug Administration approval to sell the biosimilar. Specifically, if the biosimilar manufacturer completes certain actions under the framework, such as sharing certain information about its product with the reference product manufacturer, the bill limits the number of certain patents that the reference product manufacturer may assert in a lawsuit, such as patents that were filed more than four years after the reference product received market approval. The limit shall not apply to patents claiming certain methods for using the biologic drug.

The court in which the infringement lawsuit is filed may increase the limit if justice so requires or if there is good cause for the increase.

Cosponsors 1

Members who signed on, in the order they did. All signed on Jul 25, 2019.

SeatCosponsorSigned on
R-ALMartha RobyOriginalJul 25, 2019

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseJudiciary Committee
Referred Jul 25, 2019Markup Nov 21, 2019
Courts, Intellectual Property, Artificial Intelligence, and the Internet Subcommittee
Referred Aug 28, 2019Discharged Nov 19, 2019

Actions 6

Everything that happened, newest first.

  1. Nov 21, 2019Committee Consideration and Mark-up Session Held.
  2. Nov 21, 2019Ordered to be Reported (Amended).
  3. Nov 19, 2019Subcommittee on Courts, Intellectual Property, and the Internet Discharged.
  4. Aug 28, 2019Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
  5. Jul 25, 2019Introduced in House
  6. Jul 25, 2019Referred to the House Committee on the Judiciary.

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Constitutional authority

[Pages H7468-H7469] From the Congressional Record Online through the Government Publishing Office [ www.gpo.gov ] By Mr. JOHNSON of Georgia: H.R. 3991. Congress has the power to enact this legislation pursuant to the following: U.S. Constitution, Article I, Section 8.

The sponsor’s statement, as printed in the Congressional Record, vol. 165, no. 126, July 25, 2019, page H7469.

CRS reports 2

Congressional Research Service work that CRS links to this bill or the law it became, newest first.

Cite it 2

Products on other subjects that cite it, usually among other measures.

Related bills 3

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
S 1416Affordable Prescriptions for Patients Act of 2019Related billJun 28, 2019
HR 2486FUTURE ActRelated billJul 23, 2020
HR 2884Affordable Prescriptions for Patients Through Improvements to Patent Litigation ActReintroduced BillSep 30, 2021

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To amend title 35, United States Code, to clarify and improve the process for subsection (k) applicants to resolve patent infringement claims for biological products (commonly known as the "patent dance"), and for other purposes.
Short Title(s) as Introduced
Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act of 2019

Subjects

Assigned by the Library of Congress. Policy area: Commerce.

Text 1

Each version as it was printed, newest first.

  1. Jul 25, 2019Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.